From October 1, 2023 to December 31, 2023, the company has repurchased 2,800,000 shares, representing 5.17% for $26 million. With this, the company has completed the repurchase of 3,014,289 shares, representing 5.57% for $28.24 million under the buyback announced on December 6, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.14 USD | +1.45% |
|
+3.53% | +34.50% |
Jul. 10 | Nephron Initiates CareDx at Hold Rating With $15 Price Target | MT |
Jul. 01 | CareDx, Inc(NasdaqGM:CDNA) added to Russell 3000 Growth Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.50% | 842M | |
-36.40% | 8.68B | |
+16.60% | 3.86B | |
+6.77% | 2.43B | |
-27.10% | 1.84B | |
-17.88% | 1.73B | |
+33.74% | 1.16B | |
-8.30% | 702M | |
-17.76% | 594M | |
-18.19% | 239M |
- Stock Market
- Equities
- CDNA Stock
- News CareDx, Inc
- Tranche Update on CareDx, Inc's Equity Buyback Plan announced on December 6, 2022.